756 related articles for article (PubMed ID: 11110515)
1. Role of growth hormone in chronic heart failure: therapeutic implications.
Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
[TBL] [Abstract][Full Text] [Related]
2. Role of growth hormone in chronic heart failure. Therapeutic implications.
Volterrani M; Manelli F; Cicoira M; Lorusso R; Giustina A
Drugs; 2000 Oct; 60(4):711-9. PubMed ID: 11085197
[TBL] [Abstract][Full Text] [Related]
3. Does growth hormone play a role in chronic heart failure?
Volterrani M; Giustina A; Lorusso R; Giordano A
Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
[TBL] [Abstract][Full Text] [Related]
4. The role of the GH/IGF-I axis for cardiac function and structure.
Isgaard J; Tivesten A; Friberg P; Bengtsson BA
Horm Metab Res; 1999; 31(2-3):50-4. PubMed ID: 10226781
[TBL] [Abstract][Full Text] [Related]
5. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans.
Böger RH
J Endocrinol Invest; 1999; 22(5 Suppl):75-81. PubMed ID: 10442575
[TBL] [Abstract][Full Text] [Related]
8. [Dilated cardiomyopathy and growth hormone].
Dreifuss P
Z Kardiol; 2002 Dec; 91(12):973-7. PubMed ID: 12490987
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone resistance in chronic heart failure and its therapeutic implications.
Cicoira M; Kalra PR; Anker SD
J Card Fail; 2003 Jun; 9(3):219-26. PubMed ID: 12815572
[TBL] [Abstract][Full Text] [Related]
10. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
[TBL] [Abstract][Full Text] [Related]
11. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
12. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
13. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of dilated cardiomyopathy with recombinant human growth hormone].
Osterziel KJ; Markus U; Willenbrock R; Strohm O; Dietz R
Z Kardiol; 1997 Oct; 86(10):803-11. PubMed ID: 9454447
[TBL] [Abstract][Full Text] [Related]
15. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of terminal dilated cardiomyopathy with growth hormone].
Dreifuss P
Z Kardiol; 1998 Jun; 87(6):425-35. PubMed ID: 9691412
[TBL] [Abstract][Full Text] [Related]
17. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
19. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone and the cardiovascular function.
Svensson J; Tivesten A; Isgaard J
Minerva Endocrinol; 2005 Mar; 30(1):1-13. PubMed ID: 15877009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
